<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; News by Region</title>
	<atom:link href="http://www.bioscreening.net/category/news-by-region/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>EPIX Pharmaceuticals Achieves Milestone from Collaboration with Cystic Fibrosis Foundation Therapeutics</title>
		<link>http://www.bioscreening.net/2009/03/13/epix-pharmaceuticals-achieves-milestone-from-collaboration-with-cystic-fibrosis-foundation-therapeutics/</link>
		<comments>http://www.bioscreening.net/2009/03/13/epix-pharmaceuticals-achieves-milestone-from-collaboration-with-cystic-fibrosis-foundation-therapeutics/#comments</comments>
		<pubDate>Fri, 13 Mar 2009 05:31:45 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Biotech & Pharma Law]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/03/13/epix-pharmaceuticals-achieves-milestone-from-collaboration-with-cystic-fibrosis-foundation-therapeutics/</guid>
		<description><![CDATA[LEXINGTON, Mass.&#8211;(BUSINESS WIRE)&#8211;Mar 11, 2009 &#8211; EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it has achieved another milestone in its collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit affiliate [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/03/13/epix-pharmaceuticals-achieves-milestone-from-collaboration-with-cystic-fibrosis-foundation-therapeutics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prous Institute Presents Innovative Approach to Drug Discovery</title>
		<link>http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/</link>
		<comments>http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/#comments</comments>
		<pubDate>Tue, 03 Mar 2009 07:44:41 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/</guid>
		<description><![CDATA[BARCELONA, February 26 /PRNewswire/ &#8212; Prous Institute for Biomedical Research today presented its strategies for drug discovery on its newly designed website (http://www.prousresearch.com). A large computational project with basic research support and broad disease coverage is being developed at Prous Institute under the broad-based Epistemic Drug Discovery(R) project. President and C.E.O. of the Institute, Dr. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioFocus DPI Extends Drug Discovery Collaboration with Lilly Drug Discovery &amp; Development</title>
		<link>http://www.bioscreening.net/2009/02/25/biofocus-dpi-extends-drug-discovery-collaboration-with-lilly-drug-discovery-development/</link>
		<comments>http://www.bioscreening.net/2009/02/25/biofocus-dpi-extends-drug-discovery-collaboration-with-lilly-drug-discovery-development/#comments</comments>
		<pubDate>Thu, 26 Feb 2009 03:56:16 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Biotech & Pharma Law]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/02/25/biofocus-dpi-extends-drug-discovery-collaboration-with-lilly-drug-discovery-development/</guid>
		<description><![CDATA[BioFocus DPI has extended its drug discovery agreement with Eli Lilly and Company until end 2009. Under the terms of the agreement, BioFocus DPI will identify active compounds by screening of Lillyâ€™s library compounds. The agreement extension announced today builds on the successful collaboration begun in March 2005. BioFocus DPI has been working with Lilly [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/02/25/biofocus-dpi-extends-drug-discovery-collaboration-with-lilly-drug-discovery-development/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease</title>
		<link>http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/</link>
		<comments>http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/#comments</comments>
		<pubDate>Mon, 01 Dec 2008 16:59:49 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/</guid>
		<description><![CDATA[Combination of Proprietary Drug Targets and Unique Technologies to Create Range of New Therapeutic Antibodies MUNICH, GERMANY &#8212; (Marketwire) &#8212; 11/26/08 &#8212; MorphoSys AG (FSE: MOR; Prime StandardSegment, TecDAX) and Galapagos NV (Euronext: GLPG) announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The difficulties of Cushingâ€™s syndrome</title>
		<link>http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/</link>
		<comments>http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:55:25 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Cushingâ€™s syndrome]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/</guid>
		<description><![CDATA[Diagnosing and treating Cushingâ€™s syndrome is sometimes just as difficult as it was 70 years ago. For as long as it has been described, Cushingâ€™s syndrome has presented physicians with a problem. Harvey Cushing first described it in 1932, and the diagnosis, differential diagnosis and treatment of Cushingâ€™s have remained a major challenge for endocrinologists [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nanion Increases Throughput and Cuts Costs with a New Industrial 96-Channel Patch Clamp Screening Robot</title>
		<link>http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/</link>
		<comments>http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:38:30 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/</guid>
		<description><![CDATA[Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A new approach to functional screening of siRNA knockdown</title>
		<link>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/</link>
		<comments>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:37:56 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/</guid>
		<description><![CDATA[KINGSTON, England, Nov. 25, 2008-Guava Technologies, Inc. presented at the recent Molecular Targets &#038; Cancer Therapeutics Symposium* information on their recent advancements that describe an experimental methodology and the new GuavaÂ® Simplicity Analysis Software which exploit the advantages of plate based flow technology. These technological improvements result in an overall process that can significantly expedite [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Galapagos and Merck Serono Enter New Collaboration Agreements</title>
		<link>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/</link>
		<comments>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 20:30:09 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/</guid>
		<description><![CDATA[Mechelen, Belgium; 18 November 2008 â€“ Galapagos NV (Euronext: GLPG) announced today new collaboration agreements with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. Total value of the contracts for Galapagos is â‚¬1.1 million over one year. Galapagosâ€™ service division BioFocus DPI will provide SoftFocusÂ© compounds for use in Merck Seronoâ€™s drug discovery programs. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Green protein inhibits Alheimer&#8217;s, CSIRO scientists find</title>
		<link>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/</link>
		<comments>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 19:42:19 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/</guid>
		<description><![CDATA[BY NYSSA SKILTON MEDICAL REPORTER 18/11/2008 CSIRO scientists have developed a way to screen for compounds that can inhibit the progression of Alzheimer&#8217;s disease. The system involves using live yeast and a protein called Abeta fused to a fluorescent green protein, which comes from jellyfish. The scientists, working within CSIRO&#8217;s Preventive Health Flagship, published their [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists seek out Alzheimer&#8217;s enemies</title>
		<link>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/</link>
		<comments>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 19:24:14 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/</guid>
		<description><![CDATA[CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimerâ€™s disease. In a paper published in the Journal of Alzheimerâ€™s Disease, folate is shown to be beneficial in the screening system. Lead author, CSIROâ€™s Dr Ian Macreadie says folate [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GEN Reports on the Trend Toward Predictive Toxicogenomics</title>
		<link>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/</link>
		<comments>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 17:00:22 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/</guid>
		<description><![CDATA[NEW ROCHELLE, N.Y., Nov 19, 2008 /PRNewswire via COMTEX/ &#8212; Biotech scientists increasingly are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates on a variety of organ systems, reports Genetic Engineering &#038; Biotechnology News (GEN). They are especially interested in figuring out a new compound&#8217;s mechanism of action [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Thermo Electron Corp.</title>
		<link>http://www.bioscreening.net/2005/06/13/thermo-electron-corp/</link>
		<comments>http://www.bioscreening.net/2005/06/13/thermo-electron-corp/#comments</comments>
		<pubDate>Mon, 13 Jun 2005 21:02:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[North America]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/06/13/thermo-electron-corp/</guid>
		<description><![CDATA[Patricia Henson, Raman Product Manager In order to better understand solid state compounds that are candidates for new drugs, pharmaceutical companies are employing new technologies in the screening of hundreds of compounds on a daily basis. An important factor in solid state drug forms is polymorphismâ€”a solid-state phenomenon whereby an element or compound can exist [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/06/13/thermo-electron-corp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

